Work

Treatment of Alopecia Areata With Tofacitinib

Year: 2017
Type: article
Study design: Observational Study
Abstract: Treatment of Alopecia Areata With TofacitinibTofacitinib citrate is a Janus kinase 1/3 inhibitor approved for the treatment of rheumatoid arthritis, but it has recently been used to treat alopecia areata (AA).[1][2][3] In this study, investigators searched the medical records of the Cleveland Clinic for any patients with confirmed AA who were treated with oral tofacitinib (Xeljanz; Pfizer) using a standardized, systematic treatment regimen.
Institution: Cleveland Clinic
Language: English
Subfield: Dermatology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W2602000480
FWCI: 11.4
Cites: 5
Cited by: 117
Related to: 10